BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35368070)

  • 21. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.
    Gardner CJ; Mattsson AF; Daousi C; Korbonits M; Koltowska-Haggstrom M; Cuthbertson DJ
    Eur J Endocrinol; 2015 Apr; 172(4):371-81. PubMed ID: 25583905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of growth hormone replacement therapy in Japanese adults with growth hormone deficiency: a post-marketing observational study.
    Shimatsu A; Tai S; Imori M; Ihara K; Taketsuna M; Funai J; Tanaka T; Teramoto A; Irie M; Chihara K
    Endocr J; 2013; 60(10):1131-44. PubMed ID: 23823978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone.
    Holmer H; Svensson J; Rylander L; Johannsson G; Rosén T; Bengtsson BA; Thorén M; Höybye C; Degerblad M; Bramnert M; Hägg E; Edén Engström B; Ekman B; Norrving B; Hagmar L; Erfurth EM
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3560-7. PubMed ID: 17623762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
    Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
    Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
    Verhelst J; Mattsson AF; Luger A; Thunander M; Góth MI; Koltowska-Häggström M; Abs R
    Eur J Endocrinol; 2011 Dec; 165(6):881-9. PubMed ID: 21969523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Long-Term Growth Hormone Replacement Therapy on Metabolic and Cardiovascular Parameters in Adult Growth Hormone Deficiency: Comparison Between Adult and Elderly Patients.
    Scarano E; Riccio E; Somma T; Arianna R; Romano F; Di Benedetto E; de Alteriis G; Colao A; Di Somma C
    Front Endocrinol (Lausanne); 2021; 12():635983. PubMed ID: 33716985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer International Metabolic Database).
    Verhelst J; Kendall-Taylor P; Erfurth EM; Price DA; Geffner M; Koltowska-Häggström M; Jönsson PJ; Wilton P; Abs R
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4636-43. PubMed ID: 15928246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
    Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
    Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth Responses During 3 Years of Growth Hormone Treatment in Children and Adolescents With Growth Hormone Deficiency: Comparison Between Idiopathic, Organic and Isolated Growth Hormone Deficiency, and Multiple Pituitary Hormone Deficiency.
    Lim HH; Kim YM; Lee GM; Yu J; Han HS; Yu J
    J Korean Med Sci; 2022 Mar; 37(11):e90. PubMed ID: 35315601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influences on quality of life in GH deficient adults and their effect on response to treatment.
    Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dyslipidaemia and growth hormone deficiency - A comprehensive review.
    Hepprich M; Ebrahimi F; Christ E
    Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101821. PubMed ID: 37821339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone (GH) replacement in hypopituitary adults with GH deficiency evaluated by a utility-weighted quality of life index: a precursor to cost-utility analysis.
    Kołtowska-Häggström M; Kind P; Monson JP; Jonsson B
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):122-9. PubMed ID: 17803700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.
    Feldt-Rasmussen U; Abs R; Bengtsson BA; Bennmarker H; Bramnert M; Hernberg-Ståhl E; Monson JP; Westberg B; Wilton P; Wüster C;
    Eur J Endocrinol; 2002 Jan; 146(1):67-74. PubMed ID: 11751070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
    Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders.
    Valassi E; Brick DJ; Johnson JC; Biller BM; Klibanski A; Miller KK
    Endocr Pract; 2012; 18(2):209-18. PubMed ID: 22440981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone deficiency in adults with hypopituitarism-What are the risks and can they be eliminated by therapy?
    Johannsson G; Ragnarsson O
    J Intern Med; 2021 Dec; 290(6):1180-1193. PubMed ID: 34605087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of growth hormone on pediatric body composition: A systematic review.
    Ferruzzi A; Vrech M; Pietrobelli A; Cavarzere P; Zerman N; Guzzo A; Flodmark CE; Piacentini G; Antoniazzi F
    Front Endocrinol (Lausanne); 2023; 14():1093691. PubMed ID: 36843617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency.
    Miljic D; Miljic P; Doknic M; Pekic S; Stojanovic M; Cvijovic G; Micic D; Popovic V
    Growth Horm IGF Res; 2013 Dec; 23(6):243-8. PubMed ID: 24041757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis.
    Klose M; Jonsson B; Abs R; Popovic V; Koltowska-Häggström M; Saller B; Feldt-Rasmussen U; Kourides I
    Eur J Endocrinol; 2009 Nov; 161 Suppl 1():S75-83. PubMed ID: 19684053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.